SIMULATIONS PLUS INC (SLP)

US8292141053 - Common Stock

45  -0.16 (-0.35%)

After market: 45 0 (0%)

News Image
10 days ago - InvestorPlace

New AI Bot Predicts These 7 Stocks Will Mint Millionaires

A new AI model has identified these stocks as "millionaire makers." Here are the AI stock picks that could deliver life-changing returns.

News Image
19 days ago - InvestorPlace

SLP Stock Earnings: Simulations Plus Beats EPS, Beats Revenue for Q2 2024

SLP stock results show that Simulations Plus beat analyst estimates for earnings per share and beat on revenue for the second quarter of 2024.

News Image
19 days ago - BusinessInsider

SLP Stock Earnings: Simulations Plus Beats EPS, Beats Revenue for Q2 2024

InvestorPlace - Stock Market News, Stock Advice & Trading Tips Simulations Plus (NASDAQ:SLP) just reported results for the second quarter of 2...

News Image
2 months ago - Market News Video

SLP Crosses Above Key Moving Average Level

News Image
3 months ago - Simulations Plus, Inc.

Simulations Plus Releases GastroPlus® Version 9.9

News Image
4 months ago - Seeking Alpha

Simulations Plus declares $0.06 dividend (NASDAQ:SLP)

Simulations Plus (SLP) declares $0.06/share quarterly dividend, in line with previous. Forward yield 0.56% Payable Feb. 5; for shareholders of record Jan. 29; e

News Image
4 months ago - InvestorPlace

SLP Stock Earnings: Simulations Plus Meets EPS, Beats Revenue for Q1 2024

SLP stock results show that Simulations Plus met analyst estimates for earnings per share but beat on revenue for the first quarter of 2024.

News Image
4 months ago - BusinessInsider

SLP Stock Earnings: Simulations Plus Meets EPS, Beats Revenue for Q1 2024

InvestorPlace - Stock Market News, Stock Advice & Trading Tips Simulations Plus (NASDAQ:SLP) just reported results for the first quarter of 20...

News Image
4 months ago - Seeking Alpha

KeyBanc sees opportunity in tech-enabled drug discovery stocks (NASDAQ:ABCL)

KeyBanc has initiated coverage of the tech-enabled drug discovery subsector, citing increasing demand for products that can help lower drug development costs. Read more here.

News Image
5 months ago - Seeking Alpha

Simulations Plus director sells stock worth $2.3M - filing (NASDAQ:SLP)

Simulations Plus director, Walter Waltosz, discloses $2.3 million worth of shares sold in recent SEC filing, amid total of 8 insider trades.